Literature DB >> 8192080

Diagnosing intracranial vasculitis: the roles of MR and angiography.

K G Harris1, D D Tran, W J Sickels, S H Cornell, W T Yuh.   

Abstract

PURPOSE: To describe our experience with MR and angiography in diagnosing intracranial vasculitis and to test the hypothesis that MR can be used to screen for patients unlikely to have vasculitis.
METHODS: Ninety-two patients who had angiography with "exclude vasculitis" as the indication or who had angiography and a clinical diagnosis of vasculitis were identified. Angiograms of all 92 patients and the MRs of the 70 patients who had both studies were reviewed.
RESULTS: Eleven patients had intracranial vasculitis. Angiography showed characteristic changes in 8. MR, performed in 9 of 11 vasculitis cases, was significantly abnormal in all 9. Among 70 patients who had both studies, 19 had MR that was completely normal or showed only incidental findings. None of these 19 was diagnosed with vasculitis. The diagnostic yield of angiography performed to exclude vasculitis was only 6%.
CONCLUSIONS: Evaluation for intracranial vasculitis should include MR. A negative MR excludes intracranial vasculitis more definitively than does a negative angiogram and makes the likelihood of finding vasculitis with angiography negligible.

Entities:  

Mesh:

Year:  1994        PMID: 8192080      PMCID: PMC8334625     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  29 in total

1.  Spinal cord involvement in primary angiitis of the central nervous system: a report of two cases.

Authors:  A Campi; G Benndorf; V Martinelli; M R Terreni; G Scotti
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

Review 2.  A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.

Authors:  Christopher Eckstein; Shiv Saidha; Michael Levy
Journal:  J Neurol       Date:  2011-09-20       Impact factor: 4.849

Review 3.  [Primary central nervous system vasculitis].

Authors:  S Schuster; T Magnus
Journal:  Z Rheumatol       Date:  2015-12       Impact factor: 1.372

4.  MR imaging and angiography of primary CNS vasculitis of childhood.

Authors:  R I Aviv; S M Benseler; E D Silverman; P N Tyrrell; G Deveber; L M Tsang; D Armstrong
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

5.  Non-atherosclerotic vascular disease in the young.

Authors:  Osvaldo Camilo; Larry B Goldstein
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

6.  Angiography of primary central nervous system angiitis of childhood: conventional angiography versus magnetic resonance angiography at presentation.

Authors:  R I Aviv; S M Benseler; G DeVeber; E D Silverman; P N Tyrrell; L M Tsang; D Armstrong
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

7.  Central nervous system angiitis: a series of 31 patients.

Authors:  Guillaume Geri; David Saadoun; Rémy Guillevin; Sophie Crozier; Catherine Lubetzki; Karima Mokhtari; Zahir Amoura; Bertrand Wechsler; Du Le Boutin; Nathalie Costedoat-Chalumeau; Yves Samson; Patrice Cacoub
Journal:  Clin Rheumatol       Date:  2013-10-06       Impact factor: 2.980

8.  Analysis of central nervous system vasculitis with diffusion-weighted imaging and apparent diffusion coefficient mapping of the normal-appearing brain.

Authors:  M L White; W L Hadley; Y Zhang; M A Dogar
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

Review 9.  High-resolution intracranial vessel wall imaging: imaging beyond the lumen.

Authors:  Matthew D Alexander; Chun Yuan; Aaron Rutman; David L Tirschwell; Gerald Palagallo; Dheeraj Gandhi; Laligam N Sekhar; Mahmud Mossa-Basha
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-01-08       Impact factor: 10.154

10.  Posterior encephalopathy with vasospasm: MRI and angiography.

Authors:  S Weidauer; J Gaa; M Sitzer; R Hefner; H Lanfermann; F E Zanella
Journal:  Neuroradiology       Date:  2003-10-22       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.